Discontinuation report THALLIUM
| Report ID | 161424 |
| Drug Identification Number | 02327945 |
| Brand name | THALLIUM |
| Common or Proper name | thallous chloride Tl 201 |
| Company Name | LANTHEUS MI CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | THALLIUM CHLORIDE |
| Strength(s) | 2MCI |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL vial |
| ATC code | V09GX |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-12-31 |
| Actual discontinuation date | |
| Remaining supply date | 2022-12-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Barring unforeseen issues, supply will be available until the discontinuation date |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
| Company contact information | lmicanada@lantheus.com 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-05-27 | French | Compare |
| v2 | 2022-05-27 | English | Compare |
| v1 | 2022-05-27 | English | Compare |
Showing 1 to 3 of 3